Tirzepatide, a recently approved medication, is generating excitement as a groundbreaking treatment for individuals facing diabetes type 2 . Unlike common diabetes drugs , it functions through a innovative mechanism, stimulating both glucagon-like peptide-1 and the GIP hormone receptors. Clinical